With the moon only 9% illuminated, the skies will be dark. This increases the chances of spotting meteors without the glare ...

Basel, June 25, 2025 – Novartis today announced that it has successfully completed its acquisition of Regulus Therapeutics Inc. (“Regulus”). With the completion of the acquisition, shares of ...

Novartis has completed its previously announced acquisition of US-based biopharmaceutical company Regulus Therapeutics for $1.7bn, strengthening its renal disease portfolio. Shares of common stock ...

Novartis has concluded its tender offer to acquire Regulus Therapeutics, with approximately 74.49% of outstanding shares validly tendered and not withdrawn by the expiration deadline on June 24, 2025.

In the hours following sunset on Saturday (June 28), the waxing crescent moon will line up with Mars and the bright star Regulus above the western horizon — before swiftly slipping out of view.

Novartis (LON: 0QLR) AG (SIX: NOVN) has completed its acquisition of Regulus Therapeutics Inc . (NASDAQ: RGLS), according to a press release statement filed with the Securities and Exchange Commission ...

Arcturus is high at 10 p.m. ... Jesse likes to stay active and holds a fourth degree black belt in Karate, ... See the crescent moon dance with Mars and the bright star Regulus this weekend.

Earth is leaving it on the far side of the sun. It's fairly high in the south, southwest sky at night. And it's Regulus, which is the elbow of Leo. Leo is lying there like a Sphinx looking to the ...

Basel, June 25, 2025 - Novartis today announced that it has successfully completed its acquisition of Regulus Therapeutics Inc. ("Regulus"). With the completion of the acquisition, shares of common ...

A high-level overview of Arcturus Therapeutics Holdings Inc. (ARCT) stock. View (ARCT) real-time stock price, chart, news, analysis, analyst reviews and more.